American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, BonowROCarabelloBAChatterjeeK. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol2006; 48: e1–148.
2.
Iturbe-AlessioIFonsecaMCMutchinikOSantosMAZajaríasASalazarE. Risk of anticoagulation therapy in pregnant women with artificial heart valves. N Engl J Med1986; 315: 1390–3.
3.
BornDMartinezEEAlmeidaPASantosDVCarvalhoACMoronAF. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J1992; 124: 413–7.
4.
VitaleNDe FeoMDe SantoLSPolliceATedescoNCotrufoM. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol1999; 33: 1637–41.
5.
DavidTEIvanovJArmstrongSFeindelCMCohenG. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg2001; 121: 268–77.
6.
El ShaerFHassanWLatrocheBHelalySHegazyHShahidM. Pregnancy has no effect on the rate of structural deterioration of bioprosthetic valves: long-term 18-year follow up results. J Heart Valve Dis2005; 14: 481–5.
